Recente wetenschappelijke publicaties

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) Derisbourg Sara
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) Goffard Jean-Christophe
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.
Auteurs Vercoutere A, Zina MJ, Telis M, Goffard JC, Boulvain M, de Doncker L, Derisbourg S, Houben S, Delforge ML, Daelemans C, Kelen D
Auteurs (entité) BOULVAIN MICHEL
Revue BMC Infect Dis
Date de publication 2024-05

Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Bucalau Ana-Maria
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Navez Julie
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Loi Patrizia
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Pezzullo Martina
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Van Laethem Jean-Luc
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.
Auteurs Ziane Bouziane S, Mans L, Bucalau AM, Demetter P, Pezzullo M, Andre C, Loi P, Navez J, Marcelis L, Puleo F, Charette N, Closset J, Van Laethem JL
Auteurs (entité) Mans Laura
Revue Eur J Cancer
Date de publication 2024-05

Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies.

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet

Erasme hospital

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus

Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis